At present, there is no specific drug for the treatment of new crowns, and the clinical effects of Pfizer’s new crowns oral medication are considered to be related to the individual’s physical condition, the extent of the disease, and so on, and cannot be generalized. According to the National Health and Health Commission to adjust the “new coronavirus pneumonia diagnosis and treatment program” antiviral treatment, Pfizer new crown oral drug Nematrevir tablets / ritonavir tablets combination package that is Paxlovid, applicable to the population for the onset of the onset of 5 days or less of the light and ordinary type and accompanied by the progression of the high risk of severe disease risk factors in adults. It is indicated for the treatment of adults with mild to moderate novel coronavirus pneumonia with high risk factors for progression to severe disease, such as those with advanced age, chronic kidney disease, diabetes mellitus, cardiovascular disease, chronic lung disease, and other high risk factors for severe disease. As the current domestic epidemic is recurring and still showing a trend of multi-point dissemination, the application of Pfizer’s new coronavirus oral drug can effectively curb the speed of disease transmission, improve the cure rate, and reduce the mortality rate. In addition, the prevention of new crown pneumonia should start from oneself, at this stage, should avoid going to crowded places, avoid gatherings, go out and need to standardize the wearing of masks, to do hand-washing, to strengthen their own physical fitness, to reduce the chances of falling ill. Drugs need to be taken under the guidance of a doctor, avoid self-medication. [Tip] This article refers to the “new coronary pneumonia, new coronary virus pneumonia”, etc., has been December 26, 2022, the National Health Commission issued a notice to change the name to “new coronary virus infection”.